In this study, we used mifepristone (RU486), a GR inhibitor has gained great interest regarding its potential use as an anticancer agent where it has demonstrated significant growth inhibition and antitumor effects on various human cancer cell lines (26, 27). Here, NR3C1 is linked to cancer.